Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 Next >
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Breaking news Pharmaceuticals Business
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Altimmune Inc Healthy Returns Viking Therapeutics Inc
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Biotechnology Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Breaking news Pharmaceuticals Business
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Biotechnology Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Merck & Co Inc
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Health & Science Novo Nordisk A/S Health care industry
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Eli Lilly and Co Pharmaceuticals Zealand Pharma A/S
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Healthy Returns UnitedHealth Group Inc Science
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Pharmaceuticals Business Biotechnology
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Novo Nordisk A/S Markets Stock Picks
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags CVS Health Corp Eli Lilly and Co Health care industry
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Paramount Global NVIDIA Corp Markets
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Tesla Inc Stock indices and averages Economic policy
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Wall Street Prescription drug costs Diabetes
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Pharmaceuticals Health care industry Science
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Health & Science Healthy Returns Gilead Sciences Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Zealand Pharma A/S Eli Lilly and Co Health care industry
From CNBC.com News
5 things to know before the stock market opens
Tags Nasdaq Inc Walt Disney Co 5 Things to Know
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Business News Biotechnology US: News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Novo Nordisk A/S Europe News Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags CNBC Changemakers Alphabet Inc Health care industry
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Novo Nordisk A/S World Economy Europe Markets
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee healthcare benefits Weight loss diets Employee benefits
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.